Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Saman Bahram"'
Publikováno v:
Heliyon, Vol 10, Iss 10, Pp e30982- (2024)
In the realm of petrochemical operations, persistent efforts have been made to curtail specific energy consumption; however, certain heat sources continue to be underutilized. This paper investigates the condition of a Lurgi methanol plant to identif
Externí odkaz:
https://doaj.org/article/bcf58e8d92804733af6f65e650139e75
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 24, Iss 5, Pp 650-656 (2021)
Objective(s): β-LAPachone (B-LAP) is a natural product with established anti-inflammatory properties. In this study, we investigated the protective potential of B-LAP against diabetic nephropathy in streptozotocin (STZ) induced diabetic mice.Materia
Externí odkaz:
https://doaj.org/article/ebca1f8604dc4c4c9bce01d29e90faa6
Autor:
Saman Bahram, Ahsan Wahab, Tehniat Faraz, Hamid Ehsan, Adeel Masood, Abdul Hannan, Karun Neupane, Faiz Anwer
Publikováno v:
Journal of Blood Medicine
Treatment options are limited for multiple myeloma patients who have developed four/five drug-refractory disease. Selinexor (Sel) and belantamab mafodotin (belamaf) were recently approved by the US FDA for treatment of RRMM. The toxicity profile of t
Autor:
Razwana Khanam, Zinath Roksana, Aleena Naeem, Rameesha Mehreen, Mohammad Ebad Ur Rehman, Zunairah Shah, Kiran Kuriakose, Saman Bahram, Faiz Anwer
Publikováno v:
Blood. 140:12127-12128
Autor:
Syed Adeel Hassan, Usman Ali Akbar, Saman Bahram, Sudeep Yadav, Vivek Soorya Sathya Moorthy, Adnan Mehboob Qureshi, Sheref A Elseidy, Atif Irfan Khan, Faiz Anwer
Publikováno v:
Blood. 138:4215-4215
Introduction Immune thrombocytopenic purpura (ITP) is an autoimmune disorder consisting of low platelet count, purpura, and hemorrhagic episodes, caused by antiplatelet autoantibodies. Children who develop chronic or refractory ITP are at risk of ble
Autor:
Nazma Hanif, Hira Shaikh, Muhammad Salman Faisal, Abdul Rafae, Faiz Anwer, Mohammad Ebad Ur Rehman, Vinayak Aryal, Saman Bahram, Tehniat Faraz, Adeel Masood, Karun Neupane, Laila Khalid, Zahoor Ahmed
Publikováno v:
Blood. 138:4642-4642
Introduction: Myeloproliferative neoplasms (MPN) include essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). Pregnancy in the presence of MPN increases the risk of thrombosis, hemorrhagic events, pre-eclampsia, pro
Autor:
Muhammad Saad Farooqi, Mydah Sajid Hashmi, Abdul Jabbar Dar, Saman Bahram, Zahoor Ahmed, Arshia Akbar, Zunairah Shah, Waqas Khan, Ali Shahbaz Baloch, Qasim Khurshid, Muhammad Yasir Anwar, Muhammad Ali Aziz, Faiz Anwer
Publikováno v:
Blood. 136:40-41
Background: Low-risk Myelodysplastic Syndromes (MDS) patients commonly present with anemia and may become blood transfusions dependent upon progression. Luspatercept, a targeted drug for an activin receptor ligand has emerged as new anemia treatment
Autor:
Faiz Anwer, Anum Javaid, Saman Bahram, Muhammad Yasir Anwar, Muhammad Ali Aziz, Harsh Patel, Qasim Khurshid, Arshia Akbar, Zunairah Shah, Waqas Khan, Neelam Asghar, Abdul Jabbar Dar, Zahoor Ahmed
Publikováno v:
Blood. 136:25-26
Background: Conditioning regimen given before allogeneic hematopoietic stem cell transplantation (allo-HSCT) contributes significantly to the outcomes following transplant for myelodysplastic syndrome (MDS). Myeloablative conditioning (MAC) regimens
Autor:
Mobeen Zaka Haider, Moazzam Shahzad, Muhammad Umair Mushtaq, Abdul Hannan, Karun Neupane, Tehniat Faraz Ahmed, Adeel Masood, Saman Bahram, Faiz Anwer, Hamid Ehsan, Ahsan Wahab
Publikováno v:
Journal of Clinical Oncology. 39:e20014-e20014
e20014 Background: Selinexor (Sel) and belantamab mafodotin (belamaf) were recently approved by the US FDA for treatment of relapsed/refractory multiple myeloma on July 2019 and August 2020 respectively. The toxicity profile of these drugs is a conce
Publikováno v:
Acta Medica Iranica, Vol 60, Iss 1 (2022)
Despite dietary/lifestyle modifications as well as glycemic and lipid control, non-alcoholic fatty liver disease (NAFLD) imposes a considerable risk to the patients by advancing to non-alcoholic steatohepatitis (NASH). The present investigation aims
Externí odkaz:
https://doaj.org/article/e295d7b20fa74dc1bd422570e4d431b1